Evidence map›Paper›PMID 36199167›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Expedient Synthesis of a Library of Heparan Sulfate-Like "Head-to-Tail" Linked Multimers for Structure and Activity Relationship Studies.

Jicheng Zhang, Li Liang, Weizhun Yang, Sherif Ramadan, Kedar Baryal, Chang-Xin Huo, Jamie J Bernard, Jian Liu, Linda Hsieh-Wilson, Fuming Zhang and 2 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. HPLC-Based Automated Synthesis and Purification of Carbohydrates.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Heparan sulfate glycomimeticsChemical science · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jicheng ZhangDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
Li LiangDepartment of Chemistry & Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Weizhun YangDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
Sherif RamadanDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
Kedar BaryalDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
Chang-Xin HuoDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
Jamie J BernardDepartment of Pharmacology & Toxicology, Michigan State University, East Lansing, MI 48824, USA.
Jian LiuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Linda Hsieh-WilsonDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Fuming ZhangDepartment of Chemistry & Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Robert J LinhardtDepartment of Chemistry & Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Xuefei HuangDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-6468-5526

Funding

Homogeneous Heparan Sulfate Glycopeptides: Synthetic and Functional StudiesR01GM072667 · NIGMS · UNIVERSITY OF TOLEDO · PI HUANG, XUEFEI · 2005 to 2024
$5.1M
Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating GlycosaminoglycansR44GM134738 · NIGMS · GLYCAN THERAPEUTICS CORPORATION · PI PAGADALA, VIJAYAKANTH · 2019 to 2021
$3.2M
Expedited Synthesis of Glycosaminoglycans Containing Defined Sulfation DomainsU01GM116262 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HSIEH-WILSON, LINDA C, HUANG, XUEFEI · 2015 to 2018
$2.8M
Mechanistic role of obesity in benzo(a)pyrene-initiated cancerR01ES030695 · NIEHS · MICHIGAN STATE UNIVERSITY · PI BERNARD, JAMIE J · 2020 to 2023
$1.5M
Biacore T200 Surface Plasmon Resonance SpectroscopyS10OD028523 · OD · RENSSELAER POLYTECHNIC INSTITUTE · PI LINHARDT, ROBERT J · 2020 to 2020
$344k
NIEHS NIH HHS R01 ES030695NIGMS NIH HHS R01 GM072667NIGMS NIH HHS R44 GM134738NIGMS NIH HHS U01 GM116262NIH HHS S10 OD028523
6 · The paper itself

Abstract

Heparan sulfate (HS) plays important roles in many biological processes. The inherent complexity of naturally existing HS has severely hindered the thorough understanding of their structure-activity relationship. To facilitate biological studies, a new strategy has been developed to synthesize a HS-like pseudo-hexasaccharide library, where HS disaccharides were linked in a "head-to-tail" fashion from the reducing end of a disaccharide module to the non-reducing end of a neighboring module. Combinatorial syntheses of 27 HS-like pseudo-hexasaccharides were achieved. This new class of compounds bound with fibroblast growth factor 2 (FGF-2) with similar structure-activity trends as HS oligosaccharides bearing native glycosyl linkages. The ease of synthesis and the ability to mirror natural HS activity trends suggest that the new head-to-tail linked pseudo-oligosaccharides could be an exciting tool to facilitate the understanding of HS biology.

Indexed as

DisaccharidesHeparan SulfateOligosaccharidesProtein BindingStructure-Activity RelationshipDisaccharidesHeparan SulfateOligosaccharidesHeparan SulfateLibrary SynthesisMimetic DesignStructure and Activity Relationship

Identifiers

PMID36199167
PMCPMC9675719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.